SCHEMBL4084432

SCHEMBL4084432

CCOC(=O)C(C)CN(CC1CCCC1)c1nc(Cl)ncc1[N+](=O)[O-]

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 2/20 0.33
PIN1 Q13526 8/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
GAA P10253 1/20 0.32
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
PRKCQ Q04759 1/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 2/20 0.31
USP2 O75604 1/20 0.31
POLB P06746 1/20 0.31
THRB P10828 1/20 0.31
S100A4 P26447 1/20 0.31
HTT P42858 1/20 0.31
RECQL P46063 1/20 0.31
VCAM1 P19320 1/20 0.31
GPR174 Q9BXC1 1/20 0.30
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4085806 0.84 KMT2A (0.38) CTSBPIN1MEN1KMT2AGAA
SCHEMBL4087952 0.84 PIN1 (0.35) PIN1ALDH1A1MAPT
SCHEMBL3674116 0.80 PDE4B (0.33) CTSBPIN1CYP2C9ALDH1A1MAPT
SCHEMBL4077957 0.77 ALDH1A1 (0.35) CTSBPIN1MEN1KMT2AGAA
SCHEMBL3673645 0.77 ALDH1A1 (0.34) CTSBPIN1MEN1KMT2AGAA
SCHEMBL1204164 0.76 PIN1 (0.35) PIN1MEN1KMT2AGAAALDH1A1
SCHEMBL4089261 0.76 PIN1 (0.43) PIN1ALDH1A1MAPT
SCHEMBL10024797 0.76 ALDH1A1 (0.35) CTSBPIN1MEN1KMT2AGAA
SCHEMBL4080840 0.75 ALDH1A1 (0.33) CTSBPIN1MEN1KMT2AGAA
SCHEMBL4085906 0.75 PIN1 (0.36) PIN1MEN1KMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517873-B2 Substituted pyrimidodiazepines HOFFMAN-LA ROCHE INC. (US) 2009-04-14 US disclosed
US-20080234255-A1 SUBSTITUTED PYRIMIDODIAZEPINES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234255-A1 SUBSTITUTED PYRIMIDODIAZEPINES PLK1, CCNI, CDK1 CTSB 3314/4885PIN1 792/4885MEN1 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.